FDA approves new type of non-opioid pain medication
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
FDA approves new painkiller that shows promise and challenges of opioid alternatives
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
Takeaways from RFK Jr.'s first confirmation hearing as Trump's nominee for health secretary
Kennedy Jr. was pressed to clarify his views on vaccines, abortion and public health priorities in the first of two senate ...
Is Johnson & Johnson (JNJ) the Safe Stock to Buy for the Long Term in 2025?
We recently published a list of 12 Safe Stocks to Buy for the Long Term in 2025. In this article, we are going to take a look ...
Y-mAbs Therapeutics' SWOT analysis: innovative cancer therapy stock faces growth hurdles
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB), a commercial-stage biopharmaceutical company with a "GOOD" InvestingPro Financial ...
Santa Rosa Press Democrat1d
RFK Jr. appears on Capitol Hill for HHS confirmation hearings
Robert F. Kennedy Jr’s confirmation hearings began Wednesday before the Senate Finance Committee. He appears before the ...
The American Journal of Managed Care1d
How FcRn Blockade Targets Myasthenia Gravis Autoantibodies
In part 2 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the challenge inherent ...
As RFK Jr. faces Senate confirmation hearings, here's where he stands on vaccines, food dyes
As Robert F. Kennedy Jr. faces his Senate confirmation hearings to lead the HHS, here's where he stands on health issues ...
Indiatimes14d
Bryan Johnson discontinues longevity drug, after concerns it may have accelerated aging
Bryan Johnson, a tech entrepreneur, has stopped using rapamycin, a drug not approved for anti-aging by the FDA, following concerns it may have aged him and caused infections. Johnson experienced ...
CBS News14d
How food brands and drugmakers are responding to FDA's ban of food dye Red 3
The FDA says that food companies will have until Jan. 15, 2027 to stop using the dye. Drugmakers will have an extra year, until January 2028, to comply with the change. Red 3, also known as ...